The times are changing in biopharma.
With the top drugmakers no longer committing most of their resources to the pandemic, biopharma is returning to its roots. But it’s clear the world is quickly changing, and so too are the companies that make up our industry.
Big Pharma companies are shuffling CEOs. Drugmakers are tapping AI to assist with drug development. Diversity in clinical trial participants and executive teams has become a top priority. Venture investors are contending with a more risk-averse world. | The times are changing in biopharma. We hope our selections for this year’s Most Influential People in Biopharma special report reflect the trends many of our readers are seeing in the industry.
